Immuno-Oncology and Technology
Издатель: Elsevier · ISSN 2590-0188 · 16 статей
- Table of Contents
- Editorial Board
- Association between brown adipose tissue activity and clinical outcomes in melanoma: a retrospective PET/CT analysis
- Germline BRCA1 pathogenic variants and T cell dysfunction
- Management of systemic lupus erythematosus and antiphospholipid syndrome during CAR-T therapy: insights from two clinical cases
- Corticosteroid exposure, tapering, and survival in immune-related colitis: a 10-year real-world melanoma cohort
- Reviving cancer vaccines in renal cell carcinoma: a new chapter in immunotherapy for kidney cancer
- Refuel and endure: improving metabolic fitness and efficacy in CAR-T therapy
- Can mRNA vaccines ‘warm up’ cold tumours?
- Motherhood’s immune legacy reshapes the breast for lasting cancer defence
- A multimodal AI biomarker PATH-ORACLE improves prediction of recurrence in stage I lung adenocarcinoma
- Normalized administered atezolizumab dose and clinical outcomes in advanced solid tumors: an exploratory analysis of the phase I PCD4989g study
- Quality of life and care experience in durable responders to immune checkpoint inhibitors for advanced or metastatic NSCLC or melanoma
- Age-related tumor mutational burden and inflammaging: a pan-cancer multi-omics study of treatment-naïve patients
- Why CD4+ T cells matter in adoptive cell therapy for solid cancers
- Moderna/Merck—first out of the gate with a personal neoantigen cancer vaccine—who else is in the race and what strategy(ies) will win?